Dear colleagues, I call this meeting to order.
Welcome to the ninth meeting of the Standing Committee on Science and Research.
The Board of Internal Economy requires that committees adhere to the following health protocols, which are in effect until June 23, 2022. All individuals wishing to enter the parliamentary precinct must be fully vaccinated against COVID-19. All those attending in person must wear a mask, except for members who are at their place during proceedings. Please contact the clerk of the committee for further information on preventative measures for health and safety.
As the chair, I will enforce these measures. As always, colleagues, I thank you for your co-operation.
Today's meeting is taking place in a hybrid format pursuant to the House Order of November 25, 2021.
I would like to outline a few rules to follow. Interpretation services are available for this meeting. You may speak in the official language of your choice. At the bottom of your screen, you may choose to hear floor audio, English or French. The “raise hand” feature is on the main toolbar should you wish to speak. When you are not speaking, your microphone should be muted. The committee clerk and I will maintain a speaking list for all members.
Colleagues, I am delighted that we have wonderful witnesses joining us tonight.
From BioCanRx, we have Dr. Stéphanie Michaud, president and chief executive officer, and Dr. John Bell, scientific director; from STEMCELL Technologies Inc., Dr. Allen Eaves, president and chief executive officer; and from Université du Québec à Rimouski, François Deschênes, rector, and Dr. Étienne Carbonneau, director, support for internationalization and government relations senior adviser.
We will now hear from our witnesses. Each group will have five minutes.
We will begin tonight with BioCanRx for five minutes, please.